Shelly Banjo
A bevy of state ballot measures passed this week reveal it's only a
matter of time before legalized marijuana use is the law of the land in
the U.S. Investors are already finding ways to buy into it.
Four states
voted on Tuesday to legalize recreational pot use, while four others
approved marijuana for medicinal purposes. That brings the number of
Americans living in states where recreational marijuana is legal up to
20 percent of the U.S. population. That percentage rises to 58 percent
and 66 percent of the U.S. population when counting states where medical
marijuana is legal and where states have decriminalized the drug,
respectively.
Federal
legalization of recreational marijuana use is probably not around the
corner. But that's almost beside the point. States are following their
own course, and will likely be even more emboldened once states-rights
advocates move into the White House, the Senate, and the House of
Representatives.
It also doesn't hurt that President-elect Donald Trump has touted his support of medical marijuana -- although his constantly shifting views on just about everything, along with Vice President-elect Mike Pence's opposition to marijuana,
cloud that stance. Perhaps that's why a Bloomberg Intelligence index of
32 public companies involved in cannabis-related products fell 7
percent on Tuesday.
Still, despite that drop -- which was concentrated in three pharma companies -- the index is up 181 percent year-to-date.
Besides
companies directly related to the production of cannabis, many of which
are characterized as pharma firms, plenty of other businesses stand to
benefit.
For one, you can bet big tobacco giants R.J. Reynolds
Tobacco Co., Altria Group Inc., and Phillip Morris International Inc.
are not standing still here. As one top tobacco executive told me last March,
these companies already know how to make money in the tightly regulated
industry of cigarettes, and marijuana will be no different.
It's
no secret e-cigarettes and products that heat tobacco rather than burn
it are also used by marijuana smokers. My colleague Tara Lachapelle
points out there's $45 billion in potential annual demand for
recreational weed in the U.S., and the tobacco companies are a perfect fit to serve this market.
Then there are companies such as The Scotts Miracle-Gro Co., which benefit from growing marijuana. In the past 18 months Scotts has been on a buying spree of
companies that make fertilizers, lighting and other supplies for
growers. The company's hydroponics business now brings in $250 million
in annual sales. Also benefiting are home-and-garden retailers and
hardware stores such as Home Depot Inc. and True Value Co., whose sales
in this area have skyrocketed in the past year.
To
find the other side of this trade, look for companies spending big
bucks to oppose pot legalization.
The alcohol industry, for example,
worries that making marijuana more available will make people drink less
alcohol, Bloomberg News's Jennifer Kaplan points out.
Sam Adams brewer Boston Beer Co. and Jack Daniel’s exporter
Brown-Forman Corp. are among those that call legal weed a threat to
their companies.
Pharmaceutical companies, fearing competition
for their anti-anxiety and other drugs, have also funded anti-pot
measures. One painkiller producer, Insys Therapeutics,
scored a victory on Tuesday as Arizona voted down a measure to legalize
recreational marijuana. Medical marijuana has been legal in that state
since 1996.
Nevertheless, if Tuesday's election taught us
anything, it's that America is changing, as are truths that some take
for granted. Legalizing marijuana is no different.
No comments:
Post a Comment